As of Wednesday close, Sana Biotechnology Inc.’s (NASDAQ:SANA) stock traded at $5.38. The average number of shares traded per day over the past five days has been 778,260 shares. 1 time new highs have been achieved over the past 5 days, with a -$0.23 fall in that time frame. In the last twenty days, the average volume was 864,085, while in the previous 50 days, it was 1,088,912.
Since last month, SANA stock retreated -10.33%. Shares of the company fell to $4.99 on 08/14/23, the lowest level in the past month. A 52-week high of $8.47 was reached on 05/23/23 after having rallying from a 52-week low of $2.99. Since the beginning of this year, SANA’s stock price has risen by 36.20% or $1.43, and marked a new high 17 times. However, the stock has declined by -36.48% since its 52-week high.
SANA stock investors should be aware that Sana Biotechnology Inc. (SANA) stock had its last reported insider trading activity 71 days ago on Jun 07. Flagship Ventures Fund V Gener, the 10% Owner of the company, disposed of 200,000 shares for $6.24 on Jun 07. It resulted in a $1,247,940 divestment by the insider. Flagship Ventures Fund V Gener sold 203,758 shares at an average price of $6.31 on Jun 06. The insider now owns 1,403,037 shares following the transaction. On May 26, 10% Owner Flagship Ventures Fund V Gener sold 82,000 shares at $6.23 apiece. The transaction was valued at $510,573.
Financial Health
In the three months ended June 29, Sana Biotechnology Inc.’s quick ratio stood at 3.00, while its current ratio was 3.00, showing that the company is able to pay off its debt. Based on annual data, SANA earned $3.09 million in gross profit and brought in $272.56 million in revenue.
While analysts expected Sana Biotechnology Inc. to report -$0.43 quarterly earnings, the actual figure was -$0.45 per share, beating the consensus estimate by -4.70%. The liabilities of Sana Biotechnology Inc. were 352.12 million at the end of its most recent quarter ended June 29, and its total debt was $113.14 million. The value of shareholders’ equity is $196.94 million.
Technical Picture
This quick technical analysis looks at Sana Biotechnology Inc.’s (SANA) price momentum. With a historical volatility rate of 50.61%, the RSI 9-day stood at 39.50% on 16 August.
With respect to its five-day moving average, the current Sana Biotechnology Inc. price is down by -4.10% percent or -$0.23. At present, SANA shares trade -10.03% below its 20-day simple moving average and +65.54% percent above its 100-day simple moving average. However, the stock is currently trading approximately -13.50% below its SMA50 and -3.76% below its SMA200.
Stochastic coefficient K was 37.41% and Stochastic coefficient D was 37.10%, while ATR was 0.32. Given the Stochastic reading of 40.74% for the 14-day period, the RSI (14) reading has been calculated as 41.25%. As of today, the MACD Oscillator reading stands at -0.03, while the 14-day reading stands at -0.12.
Analyst Ratings
TD Cowen launched its rating on Sana Biotechnology Inc. (NASDAQ: SANA) to a Market perform in a note to investors on August 14, 2023. Sana Biotechnology Inc. (SANA) has been rated Hold by analysts. According to 0 brokerage firms, SANA is a sell, and 4 firms recommend it is a Hold. There are 0 analysts who say the stock is underweight. A total of 0 analysts rate Sana Biotechnology Inc. stock as buy, with 1 recommending it as overweight.
With a median target price of $6.00, the current consensus forecast for the stock is $6.00 – $11.00. Based on these forecasts, analysts predict Sana Biotechnology Inc. (SANA) will achieve an average price target of $7.67.
